{"title":"The Effectiveness of Manual Detorsion Applied in the Emergency Department in Testicular Torsion: A Single - Center Experience of 13 Years","authors":"Hülya Yılmaz Başer, Kürşat Küçüker","doi":"10.5505/gju.2023.81300","DOIUrl":"https://doi.org/10.5505/gju.2023.81300","url":null,"abstract":"","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135594909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-11DOI: 10.22541/au.160765058.87317642/v1
Bekir Voyvoda, Ömür Memik, Murat Üstüner, Onur Karslı, L. Özcan
Objective: Our study aimed to the efficacy of silodosin in patients with LUTS associated with BPH who were not-responder to previous ARs blocker therapy. Methods: Patients who did not benefit from alpha blockers treatment, but did not want surgical treatment are included in this study. At enrollment, 75 patients and 75 patients were assigned to group 1 and group 2, respectively. Group 1 received silodosin 8 mg, group 2 received their previous α blocker. Results: Although, in group 1 mean IPSS score at baseline was 20,81±0,97, and it significantly decreased to 17,12±1,25 at third months, in group 2 no significant changes were observed. On the other hand in group 1 a decrease was also observed for both IPSS sub score was significantly reduced at third months, when it is compared with baseline. At the end of the third month, a significant improvement in this parameter was observed after switching to silodosin, as compared with first value (p< 0,05). As to the residual urine, significant improvement was observed in the silodosin group but no significant improvement was observed in group 2. Conclusion: This study was conducted to investigate the effectiveness and safety of silodosin in patients with BPH who had not achieved satisfactory symptom control with other α blockers in routine clinical practice before surgical treatment. Thus, at least patients who have different comorbidities will be protected from morbidities of surgery.
{"title":"Can We Use the Silodosin as Second Line Treatment of Benign Prostate Hyperplasia?","authors":"Bekir Voyvoda, Ömür Memik, Murat Üstüner, Onur Karslı, L. Özcan","doi":"10.22541/au.160765058.87317642/v1","DOIUrl":"https://doi.org/10.22541/au.160765058.87317642/v1","url":null,"abstract":"Objective: Our study aimed to the efficacy of silodosin in patients with\u0000LUTS associated with BPH who were not-responder to previous ARs blocker\u0000therapy. Methods: Patients who did not benefit from alpha blockers\u0000treatment, but did not want surgical treatment are included in this\u0000study. At enrollment, 75 patients and 75 patients were assigned to group\u00001 and group 2, respectively. Group 1 received silodosin 8 mg, group 2\u0000received their previous α blocker. Results: Although, in group 1 mean\u0000IPSS score at baseline was 20,81±0,97, and it significantly decreased to\u000017,12±1,25 at third months, in group 2 no significant changes were\u0000observed. On the other hand in group 1 a decrease was also observed for\u0000both IPSS sub score was significantly reduced at third months, when it\u0000is compared with baseline. At the end of the third month, a significant\u0000improvement in this parameter was observed after switching to silodosin,\u0000as compared with first value (p< 0,05). As to the residual\u0000urine, significant improvement was observed in the silodosin group but\u0000no significant improvement was observed in group 2. Conclusion: This\u0000study was conducted to investigate the effectiveness and safety of\u0000silodosin in patients with BPH who had not achieved satisfactory symptom\u0000control with other α blockers in routine clinical practice before\u0000surgical treatment. Thus, at least patients who have different\u0000comorbidities will be protected from morbidities of surgery.","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127126457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Inguinal Fistula by Suture Granuloma Post Microsurgical Varicocelectomy: A Rare Entity","authors":"A. Karaköse, Y. Yitgin","doi":"10.5505/gju.2022.44153","DOIUrl":"https://doi.org/10.5505/gju.2022.44153","url":null,"abstract":"","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123320025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Esen Yıldırım Demirdöğen, Ş. Demirdöğen, Gülsüm YİTİK TONKAZ, I. Karabulut, Y. Aksoy
{"title":"The Relationship Between Primary Monosymptomatic Enuresis Nocturna and Chronotype: A Controlled Study","authors":"Esen Yıldırım Demirdöğen, Ş. Demirdöğen, Gülsüm YİTİK TONKAZ, I. Karabulut, Y. Aksoy","doi":"10.5505/gju.2022.87596","DOIUrl":"https://doi.org/10.5505/gju.2022.87596","url":null,"abstract":"","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124099610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mehmet Sevim, Sibel Canbaz Kabay, B. Aras, Ş. Kabay
{"title":"Long-Term Effects of Percutaneous Tibial Nerve Stimulation Treatment for Neurogenic Overactive Bladder Due to Multiple Sclerosis: 24-Month Results","authors":"Mehmet Sevim, Sibel Canbaz Kabay, B. Aras, Ş. Kabay","doi":"10.5505/gju.2023.73644","DOIUrl":"https://doi.org/10.5505/gju.2023.73644","url":null,"abstract":"","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125635732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bahadır Ermeç, M. Öztürk, B. Eryıldırım, E. Ergenekon
{"title":"The Relation Between Multifocality and Clinical, Pathological and Histological Results in Renal Tumors","authors":"Bahadır Ermeç, M. Öztürk, B. Eryıldırım, E. Ergenekon","doi":"10.5505/gju.2022.41636","DOIUrl":"https://doi.org/10.5505/gju.2022.41636","url":null,"abstract":"","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130237965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Kartal, O. Alkış, Mehmet Sevim, O. Sönmez, Serkan Telli, B. Aras
Our experience with radical prostatectomy and extended pelvic lymph node dissection in the treatment of clinical T3 and its possible advantages. Abstract Objective: To evaluate the impact of radical prostatectomy (RP) and extended pelvic lymph node dissection (EPLND) on the disease process in terms of oncological outcomes and quality of life in the treatment of clinical stage cT3N0M0 prostate cancer (PCa). Materials and Methods: The data of patients with cT3N0M0 who had undergone open radical prostatectomy and extended pelvic lymph node dissection in our clinic between January 2015 and March 2021 were analyzed retrospectively. Preoperative and postoperative data were compared in terms of oncological and functional outcomes. Biochemical recurrence was accepted as detection of PSA >0.2 ng/ml on consecutive measurements and biochemical disease-free survival time was calculated. Results: The mean age of 23 operated patients who met the study criteria, was 66.8±7.4 years. In the pathological staging, the organ-confined disease was detected in 10 (43.4%) patients. Surgical margin positivity was observed in 6 (26.2%), while lymph node positivity in 3 (13.1%) patients. Biochemical recurrence was detected in 7 (30.2%) patients during a mean follow-up period of 33.6±22.9 months. The mean biochemical disease-free survival time was 48.4±6.3 months. In the evaluations of the patients at the postoperative 6 th months, a 3.2±2.2-point decrease was found in the International Prostate Symptom Score (IPSS) (p=0.001) and a 13.1±5.0 point decrease in the International Index of Erectile Function (IIEF) score (p=<0.001). Conclusion: Radical prostatectomy and extended pelvic lymph node dissection applied in the treatment of locally advanced prostate cancer is seem to be an effective and safe treatment method in terms of oncological and functional outcomes.
{"title":"Our Experience with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in the Treatment of Clinical Stage T3 Prostate Cancer and Its Possible Advantages","authors":"I. Kartal, O. Alkış, Mehmet Sevim, O. Sönmez, Serkan Telli, B. Aras","doi":"10.5505/gju.2022.02986","DOIUrl":"https://doi.org/10.5505/gju.2022.02986","url":null,"abstract":"Our experience with radical prostatectomy and extended pelvic lymph node dissection in the treatment of clinical T3 and its possible advantages. Abstract Objective: To evaluate the impact of radical prostatectomy (RP) and extended pelvic lymph node dissection (EPLND) on the disease process in terms of oncological outcomes and quality of life in the treatment of clinical stage cT3N0M0 prostate cancer (PCa). Materials and Methods: The data of patients with cT3N0M0 who had undergone open radical prostatectomy and extended pelvic lymph node dissection in our clinic between January 2015 and March 2021 were analyzed retrospectively. Preoperative and postoperative data were compared in terms of oncological and functional outcomes. Biochemical recurrence was accepted as detection of PSA >0.2 ng/ml on consecutive measurements and biochemical disease-free survival time was calculated. Results: The mean age of 23 operated patients who met the study criteria, was 66.8±7.4 years. In the pathological staging, the organ-confined disease was detected in 10 (43.4%) patients. Surgical margin positivity was observed in 6 (26.2%), while lymph node positivity in 3 (13.1%) patients. Biochemical recurrence was detected in 7 (30.2%) patients during a mean follow-up period of 33.6±22.9 months. The mean biochemical disease-free survival time was 48.4±6.3 months. In the evaluations of the patients at the postoperative 6 th months, a 3.2±2.2-point decrease was found in the International Prostate Symptom Score (IPSS) (p=0.001) and a 13.1±5.0 point decrease in the International Index of Erectile Function (IIEF) score (p=<0.001). Conclusion: Radical prostatectomy and extended pelvic lymph node dissection applied in the treatment of locally advanced prostate cancer is seem to be an effective and safe treatment method in terms of oncological and functional outcomes.","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114501156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Elevated uric acid (UA) and low levels of high-density lipoprotein (HDL) cholesterol are associated with cardiovascular events and mortality. Erectile dysfunction (ED) has been considered an early marker of cardiovascular disease (CVD). Therefore, this study aimed to investigate the uric acid/ HDL ratio (UHR) as a nowel marker in patients with ED. Materials and Methods: The study included 147 patients with a mean age of 50 years (range 32-76 years). Retrospective analyses were performed on the patients who were admitted to urology outpatient clinics. The laboratory parameter results were retrieved from the hospital medical records, and the UHR value was calculated. Patients were categorized into three groups according to the International Index of Erectile Function (IIEF) score. UHR was compared between groups, and its predictive value was evaluated using regression analysis and ROC curve analysis. Results: Age was found to be significantly different in all three groups (Groups 1-2, p=0.001; Groups 1-3, p=0.000; Groups 2-3, p=0.001). It was observed that the degree of ED increased with age. The values of UA and HDL were similar in all groups (p>0.05). In contrast, the UHR value was statistically significantly higher 0.15 (0.083-0.288, p =0.047) in the moderate-severe ED (Group 3). ROC curve analyses revealed that UHR predicted severe ED (IIEF 5-11) with 42.9% sensitivity and 87.3% specificity (AUC:0.66, CI 95% 0.538-0.781, p=0.019). Conclusion: UHR may serve as a severe ED indicator in patients admitted to the cardiology outpatient clinic since it has a significant association with a low IIEF score.
{"title":"Is There Any Association Between Uric Acid to High-density Lipoprotein Cholesterol Ratio and Erectile Dysfunction?","authors":"Dilay Karabulut, M. Yenice","doi":"10.5222/gju.2021.00719","DOIUrl":"https://doi.org/10.5222/gju.2021.00719","url":null,"abstract":"Objective: Elevated uric acid (UA) and low levels of high-density lipoprotein (HDL) cholesterol are associated with cardiovascular events and mortality. Erectile dysfunction (ED) has been considered an early marker of cardiovascular disease (CVD). Therefore, this study aimed to investigate the uric acid/ HDL ratio (UHR) as a nowel marker in patients with ED. Materials and Methods: The study included 147 patients with a mean age of 50 years (range 32-76 years). Retrospective analyses were performed on the patients who were admitted to urology outpatient clinics. The laboratory parameter results were retrieved from the hospital medical records, and the UHR value was calculated. Patients were categorized into three groups according to the International Index of Erectile Function (IIEF) score. UHR was compared between groups, and its predictive value was evaluated using regression analysis and ROC curve analysis. Results: Age was found to be significantly different in all three groups (Groups 1-2, p=0.001; Groups 1-3, p=0.000; Groups 2-3, p=0.001). It was observed that the degree of ED increased with age. The values of UA and HDL were similar in all groups (p>0.05). In contrast, the UHR value was statistically significantly higher 0.15 (0.083-0.288, p =0.047) in the moderate-severe ED (Group 3). ROC curve analyses revealed that UHR predicted severe ED (IIEF 5-11) with 42.9% sensitivity and 87.3% specificity (AUC:0.66, CI 95% 0.538-0.781, p=0.019). Conclusion: UHR may serve as a severe ED indicator in patients admitted to the cardiology outpatient clinic since it has a significant association with a low IIEF score.","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127284420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of Hematological Parameters in Testicular Tumors","authors":"I. Evren, Y. Arıkan, D. N. Özlü, M. Ekşi","doi":"10.5505/gju.2022.52297","DOIUrl":"https://doi.org/10.5505/gju.2022.52297","url":null,"abstract":"","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131930149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Uğur Aydın, E. C. Bulut, M. Onaran, Ç. Coşkun, B. Öğüt, I. Sen
Cystic nephroma (CN) is a rare, multicystic, non-hereditary benign lesion that does not contain solid components. The fact that this entity can not be easily distinguished from other cystic tumors of kidney creates difficulties in diagnosis and treatment. We present a 37-year-old male case with incidentally detected two cystic masses in his left kidney. After nephron-sparing nephrectomy, the histopathology of one of the cystic mass of the patient was reported as renal cell cancer and the other as cystic nephroma. Cystic nephroma is a rare tumor of the kidney. Definitive diagnosis can be made histopathologically rather than using physical examination and imaging methods. We reviewed the literature by presenting our case that had 2 cystic lesions in the same kidney, one of which was renal cell cancer (RCC) and the other was cystic nephroma.
{"title":"Two Cystic Masses in the Same Kidney: Renal Cell Carcinoma and Cystic Nephroma","authors":"Uğur Aydın, E. C. Bulut, M. Onaran, Ç. Coşkun, B. Öğüt, I. Sen","doi":"10.5505/gju.2022.18209","DOIUrl":"https://doi.org/10.5505/gju.2022.18209","url":null,"abstract":"Cystic nephroma (CN) is a rare, multicystic, non-hereditary benign lesion that does not contain solid components. The fact that this entity can not be easily distinguished from other cystic tumors of kidney creates difficulties in diagnosis and treatment. We present a 37-year-old male case with incidentally detected two cystic masses in his left kidney. After nephron-sparing nephrectomy, the histopathology of one of the cystic mass of the patient was reported as renal cell cancer and the other as cystic nephroma. Cystic nephroma is a rare tumor of the kidney. Definitive diagnosis can be made histopathologically rather than using physical examination and imaging methods. We reviewed the literature by presenting our case that had 2 cystic lesions in the same kidney, one of which was renal cell cancer (RCC) and the other was cystic nephroma.","PeriodicalId":266572,"journal":{"name":"GRAND JOURNAL OF UROLOGY","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133629590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：